Susceptibility of clinical isolates of cytomegalovirus to human interferon.
about
Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complexSelective antiviral activity of human interferons on primate oncogenic and neurotropic herpesviruses.Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha.Molecular biology and immunology of cytomegalovirus
P2860
Susceptibility of clinical isolates of cytomegalovirus to human interferon.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Susceptibility of clinical isolates of cytomegalovirus to human interferon.
@ast
Susceptibility of clinical isolates of cytomegalovirus to human interferon.
@en
type
label
Susceptibility of clinical isolates of cytomegalovirus to human interferon.
@ast
Susceptibility of clinical isolates of cytomegalovirus to human interferon.
@en
prefLabel
Susceptibility of clinical isolates of cytomegalovirus to human interferon.
@ast
Susceptibility of clinical isolates of cytomegalovirus to human interferon.
@en
P2860
P356
P1476
Susceptibility of clinical isolates of cytomegalovirus to human interferon.
@en
P2093
P2860
P304
P356
10.1128/AAC.11.4.656
P407
P577
1977-04-01T00:00:00Z